TradingPro Saturday, 05/23/20 11:46:38 AM Re: None Post # of 299751 So far all the leading CV-19 vaccines and treatments have been flops or pumps with little substance. I consider B to be a front runner. The safety profile can have this in human trials ASAP once testing confirms its potential. Unreal how Gilead, AZN can pump their unproven treatments, in Gilead’s case repeatedly failed Rem treatment. AZN gets a billion for what? While IPIX has to methodically prove every possibility/angle with B. The methodical approach is proving B is the gold standard so in the end it will work out. Everyone should have to play by the same rules, it’s sickening how corrupt the process has become.